# OnCo record ilixadencel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ilixadencel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ilixadencel" ;
  schema:name "Ilixadencel"@en ;
  schema:alternateName "Intuvax"@en, "COMBIG-DC"@en ;
  schema:description "Ilixadencel is an experimental allogeneic dendritic cell product injected into the tumour from Mendus, in phase 2 trials for metastatic renal cell carcinoma, hepatocellular carcinoma and gastrointestinal stromal tumour and other cancers; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/ilixadencel/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/api/v2/studies/NCT02432846>, <https://www.mendus.com/what-we-do/>, <https://clinicaltrials.gov/search?intr=ilixadencel> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Allogeneic dendritic cell product injected into the tumour" ;
  onco:cancers <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/gist/>, <https://onco.cc/cancers/nsclc/> ;
  onco:companies <https://onco.cc/companies/mendus/> ;
  onco:trials <https://onco.cc/trials/nct02432846/>, <https://onco.cc/trials/nct01974661/>, <https://onco.cc/trials/nct02686944/>, <https://onco.cc/trials/nct03735290/> .